Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TLT vs GSK✓SelectedUSD · GSKTLT vs GSK performance historyLatest closeAs of+0.84%11/18
Stock and ETF performance explorer

TLT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-34.4%
GSK return
+42.7%
Excess return
-77.1%
Maximum drawdown
-43.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.8%-1.3%+2.2%+1.0%
7D-0.9%-3.1%+2.3%-0.5%
30D+1.4%-0.9%+2.3%+1.4%
3M-0.6%-4.2%+3.6%-0.2%
6M-1.7%-1.6%-0.1%-1.7%
YTD-4.4%+2.6%-6.9%-4.8%
1Y-5.7%+6.2%-11.9%-6.5%
3Y+1.3%+55.0%-53.6%-4.1%
5Y-34.4%+42.8%-77.3%-35.1%
All-34.4%+42.7%-77.1%-35.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling